Swiss Cancer Center Léman

Swiss Cancer Center Léman

The Swiss Cancer Center - Leman is an alliance against cancer forged between several academic and clinical institutions: the University Hospital of Lausnne , the University Hospitals of Geneva, the University of Lausanne, the University of Geneva and the Swiss Federal Institute of Technology Lausanne, as well as privileged partners. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Swiss Cancer Center Léman, Switzerland, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

83%


Total
Publications

193


Total Open
Publications

160


Total
Citations

9.2K


Open Access
Percentage

83%


Total
Publications

193


Total Open
Publications

160


Total
Citations

9.2K

Wikipedia

Website

download

Breakdown

10% 57% 16% 17%

Publisher Open

10%

Both

57%

Other Platform Open

16%

Closed

17%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

60

Hybrid 39%

51

No Guarantees 15%

19

Other Platform Open

Domain 71%

100

Institution 56%

78

Preprint 18%

25

Other Internet 11%

16

Public 8%

11

Other Platform Locations

Name

Platform Type

Publications

DOI
Other Internet
165
PubMed Central
Domain
101
Université de Lausanne - SERVAL
Institution
42
Figshare
Public
36
University of Geneva - Archive ouverte UNIGE
Institution
20
Europe PMC
Domain
20
bioRxiv
Preprint
18
Ecole Polytechnique Fédérale de Lausanne - Infoscience
Institution
12
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles
Institution
6
University of Cambridge - Apollo
Institution
4
1 / 5

Data updated 8 December 2024

Share

Share

Share